Although neither of these loci reaches genome-wide significance, mutations in either FGFR2 or PAPSS2 have been reported to result in different types of bone diseases such as skeletal dysplasia and craniosynostosis11, 12, 13, 14, 15. Here, PAPSS2 is linked to skeletal dysplasia.